Angiotensin and blood pressure
Pro Research Analysisby 
Searched over 200M research papers
The Role of Angiotensin in Blood Pressure Regulation
Angiotensinogen and Blood Pressure Modulation
Angiotensinogen, a precursor to angiotensin peptides, plays a crucial role in blood pressure regulation. The cleavage of angiotensinogen by renin releases angiotensin peptides, which are essential for controlling blood pressure. Recent studies have revealed that angiotensinogen is not merely a passive substrate but has an inherent conformational mechanism critical for the release of angiotensin peptides. This mechanism involves a shift in the amino-terminal tail of angiotensinogen, which is modulated by a labile disulfide bond. Changes in the redox status of this bond can affect angiotensin release, as seen in conditions like pre-eclampsia .
Type 1A Angiotensin II Receptor and Blood Pressure
The type 1A receptor for angiotensin II (AT1) is vital for vascular and hemodynamic responses to angiotensin II. Disruption of the AT1 receptor gene in mice has shown that the absence of this receptor leads to significantly reduced blood pressure. Mice lacking the AT1 receptor exhibit almost no pressor response to angiotensin II, highlighting the receptor's importance in blood pressure regulation . Additionally, studies have shown that genetic alterations in the expression of components of the renin-angiotensin system, including the AT1 receptor, are strongly implicated in the pathogenesis of hypertension Ito1995Fyhrquist1995.
Angiotensin II and Cardiovascular Pathophysiology
Angiotensin II (Ang II) is a potent regulator of blood pressure through mechanisms such as vasoconstriction, sympathetic nervous stimulation, and increased aldosterone biosynthesis. Ang II also contributes to cardiovascular disorders by promoting the growth and migration of vascular smooth muscle cells, leading to vascular wall thickening and fibrosis. These actions are mediated by the AT1 receptor and can be blocked by specific AT1 receptor blockers like losartan. Ang II is also involved in atherosclerosis and myocardial remodeling post-infarction, making it a significant factor in hypertension and cardiovascular disease .
Angiotensin-(1-7) and Blood Pressure
Angiotensin-(1-7) is another peptide in the renin-angiotensin system that has been shown to have varying effects on blood pressure. In a rat model of renal mass ablation, Ang-(1-7) infusion was associated with increased blood pressure and adverse cardiac remodeling, suggesting potential deleterious effects in certain conditions . Conversely, in human studies, Ang-(1-7) has been shown to lower blood pressure and improve cardiovascular autonomic function in older adults, indicating its potential therapeutic benefits in aging populations .
Genetic Polymorphisms and Blood Pressure
Genetic polymorphisms in the angiotensin-converting enzyme (ACE) gene have been linked to differences in blood pressure regulation. Studies have shown that certain ACE gene polymorphisms are associated with increased risk for hypertension and cardiovascular diseases. For instance, the ACE deletion-insertion (D/I) polymorphism has been linked to hypertension in men but not women, suggesting a sex-specific genetic influence on blood pressure . Additionally, polymorphisms in the ACE gene have been associated with variations in ACE concentration and blood pressure in different populations, highlighting the genetic complexity of blood pressure regulation .
Conclusion
The renin-angiotensin system, particularly through the actions of angiotensinogen, angiotensin II, and their receptors, plays a critical role in the regulation of blood pressure. Genetic factors, including polymorphisms in the ACE gene, further influence this regulation, contributing to the complexity of hypertension and cardiovascular diseases. Understanding these mechanisms provides valuable insights for developing targeted therapies for hypertension and related conditions.
Sources and full results
Most relevant research papers on this topic